Literature DB >> 6318303

Prevalence of antibodies to Epstein-Barr virus (EBV) in childhood and adolescence in Denmark.

J Hesse, K K Ibsen, S Krabbe, P Uldall.   

Abstract

A seroepidemiologic survey on the prevalence of antibodies to Epstein-Barr virus (EBV) in Denmark was carried out. Sera from 518 children and 178 adults were investigated for IgG antibodies to the viral capsid antigen by an immunofluorescence assay. The proportion of subjects with antibodies increased from 15% at 1 yr to 60-65% in the 4-6 yr age group, was stationary at the age of 7-14, and then increased further progressively with age, to reach about 95% in late adulthood. Among preschool children a significantly higher prevalence rate was demonstrated in the lower socioeconomic stratum, as well as a somewhat higher prevalence rate in children attending day nurseries. The study indicates that infections with EBV have a rather early and widespread occurrence in this country compared with other developed areas.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318303     DOI: 10.3109/inf.1983.15.issue-4.03

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

Review 1.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  The role of viruses in the pathogenesis of peritonsillar abscess.

Authors:  M Rusan; T E Klug; J J Henriksen; S Ellermann-Eriksen; K Fuursted; T Ovesen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-29       Impact factor: 3.267

3.  Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland.

Authors:  N S Crowcroft; A Vyse; D W Brown; D P Strachan
Journal:  J Epidemiol Community Health       Date:  1998-02       Impact factor: 3.710

4.  Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study.

Authors:  Amy M Linabery; Erik B Erhardt; Rachel K Fonstad; Richard F Ambinder; Greta R Bunin; Julie A Ross; Logan G Spector; Seymour Grufferman
Journal:  Int J Cancer       Date:  2014-03-18       Impact factor: 7.396

5.  Primary Epstein-Barr virus infection with and without infectious mononucleosis.

Authors:  Klaus Rostgaard; Henry H Balfour; Ruth Jarrett; Christian Erikstrup; Ole Pedersen; Henrik Ullum; Lars Peter Nielsen; Marianne Voldstedlund; Henrik Hjalgrim
Journal:  PLoS One       Date:  2019-12-17       Impact factor: 3.240

6.  High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.

Authors:  Nathan D Montgomery; Cara Randall; Matthew Painschab; Ryan Seguin; Bongani Kaimila; Edwards Kasonkanji; Takondwa Zuze; Robert Krysiak; Marcia K Sanders; Avian Elliott; Melissa B Miller; Coxcilly Kampani; Fred Chimzimu; Maurice Mulenga; Blossom Damania; Tamiwe Tomoka; Yuri Fedoriw; Dirk P Dittmer; Satish Gopal
Journal:  Cancer Med       Date:  2019-11-29       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.